Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Metabolic Diseases × Nutrition Assessment × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 11 Neoplasms 10 Obesity 7 Motor Activity 6 Colorectal Neoplasms 6 Prostatic Neoplasms 5 Overweight 5 Malnutrition 5 Lung Neoplasms 4 Weight Loss 3 Stomach Neoplasms 3 Pancreatic Neoplasms 3 Hypertension 3 Stroke 2 Polycystic Ovary Syndrome 2 Inflammation 2 Heart Failure 2 Heart Diseases 2 Gastrointestinal Neoplasms 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Diabetes Mellitus 2 Colonic Neoplasms 2 Cardiovascular Diseases 2 Carcinoma, Non-Small-Cell Lung 2 Cachexia 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Thinness 1 Taste Disorders 1

Interventions

fludarabine 2 Busulfan 2 thymoglobulin 1 fludarabine phosphate 1 bicalutamide 1 Testosterone 1 Saline Solution 1 Powders 1 Nutrition Assessment 1 Metformin 1 Mesna 1 Melphalan 1 Magnetic Resonance Imaging 1 Influenza Vaccines 1 Honey 1 Heparin 1 Gonadotropin-Releasing Hormone 1 Gastric Bypass 1 Exercise 1 Eating 1 Cyclophosphamide 1 Clofarabine 1 Caloric Restriction 1 Antineoplastic Agents 1 Antilymphocyte Serum 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05432856 2025-08-27

IMPACT-Women

University of Alberta

Phase NA Recruiting

Cardiovascular Diseases, Metabolic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡